Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

181 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Active, Not Recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT07076121

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • Local Institution - 0365 Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 269 locations
View Trial Details
Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

NCT04927780

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Meander Medical Center Amersfoort, Netherlands
  • Amsterdam UMC Amsterdam, Netherlands
  • OLVG Amsterdam, Netherlands
View all 21 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

NCT00878163

Conditions
Adult Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions